Heyman Richard A.

DirectorOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Jul 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$157K
Net Open-Market Flow
-$157K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2026Option exercise(M)4K$1.60$6K45K
Jul 24, 2026Sell(S)7K$12.02$84K38K
Jul 24, 2026Sell(S)6K$12.02$73K207K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 24, 2026Option exercise(M)4K$030K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001584759-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.